Recomendaçoes para o tratamento da crise migranosa: Consenso da sociedade brasileira de cefaléia

Arquivos de Neuro-Psiquiatria

Volumn 58, Issue 2 A, 2000, Pages 371-389

  Krymchantowski, Abouch Valenty ^a   Dias Gherpelli, José Luiz ^a   Topczewski, Abram ^a   Barea, Liselotte Menke ^a   Bordini, Carlos Alberto ^a   Ciciarelli, Marcelo ^a   De Souza Carvalho, Deusvenir ^a   Vega, Marcelo Gabriel ^a   Dantas, Djacir ^a   Arruda, Marco Antonio ^a   Zukerman, Eliova ^a   Kowacs, Pedro Andre ^a   Rabello, Getulio Dare ^a   Ferreira Moreira Filho, Pedro ^a   Fortini, Ida ^a   Novaretti, Tania ^a   Freitas Carvalho, João José ^a   Farias Da Silva, Wilson ^a   Maciel, Jayme Antunes ^a   Sanvito, Wilson Luiz ^a   Speciali, Jose Geraldo ^a   Dadalti, Yara Fragoso ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN AGONIST; ACETYLSALICYLIC ACID; CAFFEINE; CHLORPROMAZINE; CLONIXIN; CORTICOSTEROID; DEXAMETHASONE; DIAZEPAM; DIHYDROERGOCRISTINE; DOMPERIDONE; ERGOT ALKALOID; HALOPERIDOL; IBUPROFEN; INDOMETACIN; ISOPRENALINE; METOCLOPRAMIDE; NAPROXEN; NARATRIPTAN; PARACETAMOL; PETHIDINE; RIZATRIPTAN; SUMATRIPTAN; TOLFENAMIC ACID; ZOLMITRIPTAN;

BRAZIL; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; FEMALE; HUMAN; MALE; MIGRAINE; PRACTICE GUIDELINE; ANALGESIA; EPILEPTIC AURA; MENOPAUSE; MENSTRUATION; REVIEW;

ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRAZIL; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; SEROTONIN AGONISTS;

EID: 0042688013     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X2000000200029     Document Type: Article

References (76)

1. Ferrari M, Haan J. Drug treatment of migraine attacks. In Silberstein SD, Goadsby PJ (eds). Headache. Blue Books of Neurology, Newton:Butterworth-Heinemann, 1997:117-130.
2. Ferrari M. Roon K. The triptan war anno 1999. American Academy of Neurology. Sylabus 1999.
3. Krymchantowski AV, Barbosa JSS, Cheim C, Alves LA. Oral lysine clonixinate in the acute treatment of migraine: a double-blind study. Cephalalgia 2000: in press.
4. Krymchantowski AV. Naproxen sodium decreases migraine recurrence when administered with sumatriptan. Arq Neuropsiquiatr 2000: in press.
5. Meloche J. Triptans and migraine: Which drug for which patient ? Can J Diag 1999;16:67-77.
6. Silberstein SD, Lipton RB, Goadsby PJ. Headache in clinical practice. Oxford: Isis Medical Media, 1998:61-90.
7. Tfelt-Hansen P, McEwen J. Nonsteroidal antiinflammatory drugs in the acute treatment of migraine. In Olesen J. Tfelt-Hansen P. Welch KMA (eds). The headaches. 2.Ed. Philadelphia:Lippincot Williams & Wilkins, 2000:391-397.
8. Tfelt-Hansen P, Saxena P. Ergot alkaloids in the acute treatment of migraine. In Olesen J. Tfelt-Hansen P, Welch KMA (eds). The Headaches, 2.Ed. . Philadelphia:Lippincot Williams & Wilkins. 2000:399-409.
9. Migrânea com aura Amery WK, Waelkens J. Prevention of the last chance: an alternative pharmacologic treatment of migraine. Headache 1983;23:37-38.
10. Bates D, Ashford E, Dawson R, et al., Subcutaneous sumatriptan during the migraine aura. Neurology 1994; 44:1587-1592.
11. Hoffert MJ, Scholz MJ, Kanter R. A double-blind controlled study of nifedipine as an abortive treatment in acute attacks of migraine with aura. Cephalalgia 1992;12:323-324.
12. Kuppersmith MJ, Hass WK, Chase NE. Isoproterenol treatment of visual symptoms in migraine. Stroke 1979;10:299-305.
13. Waelkens J. Dopamine blockade with domperidone: bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia 1984;4:85-90.
14. Wolff HG. Headache and other head pain. New York: Oxford Univ Press; 1963.
15. Migrânea e mulher Becker WJ. Use of oral contraceptives in patients with migraine. Neurology 1999;53(Suppl 1):19-25.
16. Bousser M-G, Massiou H. Migraine in the reproductive cycle. In Olesen J. Tfelt-Hansen P. Welch KMA (eds). The headaches. New York : Raven Press 1993.
17. Boyle CAJ. Management of menstrual migraine. Neurology 1999;53(Suppl 1):15-18.
18. Facchinetti F, Neri I, Marlignoni E, Fioroni L, Nappi g, Genazzani AR. The association of menstrual migraine with the premenstrual syndrome. Cephalalgia 1993;13:422-425.
19. Facchinetli F, Bonellie G, Kangasniemi P, Pascual J, Shuaib A. The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. Obstet Gynecol 1995;86:911-916.
20. Fettes I. Migraine in the menopause. Neurology 1999;53(Suppl 1): 129-33.
21. Granella F, Sances G, Messa G, Marinis M, Manzoni GC. Treatment of menstrual migraine. Cephalalgia 1997;17(Suppl 20):35-38.
22. Koren G, Pastuszak A. Ito S. Drug therapy: drugs in pregnancy. N Engl J Med 1998;338:1128-1137.
23. Lignieres B, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ, Bousser MG. Prevention of menstrual migraine by percutaneous oestradiol. Br Med J 1986; 293:1540.
24. MacGregor AE. Menstruation, sex, hormones and migraine. Advances in Headache. Neurol Clin 1997;15:125-141.
25. Newman EC, Lipton RB, Lay CE, Solomon S. A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology 1998;51:307-309.
26. Pfaffenrath V. Efficacy and safety of percutaneous estradiol vs placebo in menstrual migraine. Cephalalgia 1993;13(Suppl 13):244.
27. Pradalier A, Vincent D, Beaulieu P, Baudesson G, Launay J-M. Correlation between oestradiol plasma level and therapeutic effect on menstrual migraine. In Clifford Rose F (ed). New advances in headache research, 4. London: Smith-Gordon, 1994:129-132.
28. Rapoport AM, Ramadan NM, Adelman Ju et al. Optimizing the dose of zolmitriptan (Zomig) for the acute treatment of migraine: a multicenter, double-blind, placebo controlled, dose range-finding study. Neurology 1997;49:1210-1218.
29. Sance G, Martignoni E, Fioroni L, Blandini F, Fachinetti F, Nappi G. Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache 1990; 30:705-709.
30. Silberstein SD. Migraine and pregnancy. Advances in Headache. Neurol Clin 1997;15:209-231.
31. Silberstein SD, Lipton RB, Goadsby PJ. Headache in clinical practice. Oxford: Isis Medical Media 1998.
32. Smite MG, van der Meer YG, Pfeil JPJM, Rijnierse JJMM, Vos AJM. Perimenstrual migraine: effect of estraderm TTS® and the value of contingent negative variation and exteroceptive temporalis muscle suppression test. Headache 1993;34:103-106.
33. Solbach MP, Stevenson-Waymer R. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan. Obstet Gynecol 1993;82:769-772.
34. Steiner M, Steinberg S, Stewart D, et al., Fluoxetin in the treatment of premenstrual dysphoria. N Engl J Med 1995;332:1529-1534.
35. Wainscott G, Volans GN, Sullivan FM, Wilkinson M. The outcome of pregnancy in women suffering from migraine. Postgrad Med J 1978; 54:98-102.
36. Migrânea nus doenças on condições associadas Callaham M, Raskin N A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache 1986;26:168-171
37. Cordás TA, Barretto OCO Interações Medicamentosas. São Paulo: Lemos Editorial, 1998
38. Farias da Silva W. Algias craniofaciais. São Paulo :Lemos Editorial, 1998
39. Ferrari MD. How to assess and compare drugs in the management of migraine: success rates in term of response and recurrence. Cephalalgia 1999;19:2-8.
40. Ferrari M, Haan J. Drug treatment of migraine attacks. In Silberstein SD, Goadsby PJ (eds). Headache. Blue Books of Neurology. Newton:Butterworth-Heinemann. 1997:117-130.
41. Giammarco R, Edmeads J, Dodick D Clinical decisions in headache management. London: Decker Hamilton,1998.
42. Hezog AG. Continuos bromocriptine therapy in menstrual migraine (Abstr). Neurology 1995;45:A465.
43. Lance JW, Goadsby PJ. Headache. 6 Ed. Oxford: Butterworth- Heinemann, 1998:116-157.
44. Marcolin MA Interações farmacológicas com drogas psiquiátricas. Rio de Janeiro: MEDSI, 1998.
45. Olesen J, Tfelt-Hansen P, Welch KMA The headaches 2.Ed. Philadelphia: Lippincott Williams & Wilkins, 2000.
46. PDR Generics. Medical economics. New Jersey: Montvale, 1995.
47. Pradalier A. Acute migraine attack therapy: comparison of naproxen sodium and an ergotamine tartarate compound. Cephalalgia 1985;5:107-113.
48. Rowland LP. Current neurologic drugs. Baltimore: Williams & Willians, 1998
49. Silberstein SD Agents for migraine and other headaches. Current neurologic drugs. Baltimore : Williams & Wilkins, 1998.
50. Silberstein SD, Lipton BR, Goadsby PJ. Headache in clinical practice. Oxford : Isis Medical Media, 1998.
51. Silberstein SD, Lipton BR. Overview of diagnosis and treatment of migraine. Neurology 1994;44:6-16.
52. Silberstein SD Migraine and pregnancy Neurol Clin 1997;15:209-231.
53. Silberstein SD; Saper J Migraine: diagnosis and treatment. In Dalessio D. Silberstein SD (eds). Wolff's headache and other head pain. New York: Oxford Univ Press, 1993:96-170.
54. Spierings ELH Headache. Boston : Butterworth-Heinemann, 1998.
55. Migrânea na criança e adolescência Barlow CF. Headaches and migraine in childhood. Oxford: Blackwell Scientific, 1984.
56. Davidoff RA. Migraine: manifestations, pathogenesis and management. Philadelphia: F A Davis, 1995
57. Dowson AJ, Flelcher PE, Millson DS. Efficacy and tolerability of 'Zornig' in adolescent migraine. Cephalalgia 1998;18:406.
58. th Congress of the International Headache Society, 1999.
59. Hämäl̈inen ML, Hoppu K, Valkeila E, Santavuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology 1997;48 103-107.
60. Hockaday JM. Migraine in childhood. London: Butterworths, 1988.
61. Linder ST. Subcutaneous sumatriptan in the clinical setting: the first 50 consecutive patients with acute migraine in a pediatric neurology office practice. Headache 1996;36:419-422.
62. MacDonald JT. Treatment of juvenile migraine with subcutaneous sumatriptan. Headache 1994;34:581-582.
63. th Congress of the International Headache Society, 1999.
64. Winner P. Management of childhood migraine. American Academy of Neurology. Syllabus, 1999.
65. Migrânea na unidade de emergência Andersson P, Hinge HH, Johansen O, et al. Double-blind study of naproxen vs placebo in the treatment of acute migraine attacks. Cephalalgia 1989;9:54-57.
66. Bigal ME, Bordini CA, Speciali JG Metamizol (dipirona) endovenoso no tratamento agudo da migrânea e da cefaléia tipo tensional episódica. Um estudo contra placebo controlado. Resumo enviado ao X Pan American Congress of Neurology - Cartagena de Indias, Colombia, 1999.
67. Cameron JD, Lane PL, Speechley M Intravenous chlorpromazine vs intravenous metoclopramida in acute migraine headache. Acad Emerg Med 1995;2:597-602.
68. Carpay HA, Matthijse P, Steinbuch M, Mulde PGH: Oral and subcutaneous sumatriptan in the acute treatment of migraine: an open randomized cross-over study. Cephalalgia 1997;17:591-595.
69. Gallagher RM. Emergency treatment of intractable migraine. Headache 1986;26:74-75.
70. Karabetsos A, Karachalios G, Bourlinou P, et al. Ketoprofen versus paracetamol in the treatment of acute migraine. Headache 1997;37:12-14.
71. Karachalios GN, Fotiadou A, Chrisikos N et al. Treatment of acute migraine attack with diclofenac sodium: a double blind study. Headache 1992;32:98-100.
72. Moschiano F, D'Amico D, Grazzi L, Leone M, Bussone G: Sumatriptan in the acute treatment of migraine without aura: efficacy of 50 mg dose. Headache 1997;37:421-423.
73. Pfaffenrath V, Scherzer S: Analgesic and NSAID's in the treatment of the acute migraine attack. Cephalalgia 1995;15(Suppl 1):14-20.
74. Saadah, H: Abortive migraine therapy in the office with dexametasone and prochlorperazine. Headache 1994;34:366-370.
75. Tek D, McClellan D, Olshaker M. A prospective double blind study of metoclopramide hydrocloride for the control of migraine in the emergency department. Ann Emerg Med 1990;19:1083-1087.
76. Ziegler DK Opiate and opiod use in patients with refractory headache. Cephalalgia 1994;14:14-15.